Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors. Clinics [Internet]. 2014 Apr. 1 [cited 2024 May 17];69(4):294-303. Available from: https://www.revistas.usp.br/clinics/article/view/79512